In our final ‘CSF cognition models’ (Figs 2–5), CSF biomarkers p-tau and Aß42/40 as well as cognitive variables were added while controlling for confounding variables of Alzheimer’s disease risk as outlined above. The gene discussed is MAPT; the disease is Alzheimer disease.